Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alain Chebly

Showing results (1-10 of 37) with videos related to

Pageof 4
Sort By:
Future Oncology (London, England)|August 12, 2024
Cancer cytogenetics in the era of artificial intelligence: shaping the future of chromosome analysisAlain Chebly
European Journal of Medical Genetics|June 3, 2026
Genotype before phenotype? Reversing the diagnostic odyssey in genomic medicineAlain Chebly, Said El Shamieh
Molecular Cytogenetics|July 18, 2025
Assessing the reliability of ChatGPT in cytogenetic reporting and interpretation: implications for clinical useAlain Chebly, Lauren Veronese, Edith Chevret
Ophthalmology Science|February 24, 2026
Long-read Sequencing in Inherited Retinal Dystrophies: A Systematic ReviewMariam Ibrahim, Alain Chebly, Said El Shamieh
Heliyon|November 18, 2024
A novel nonsense variant in <i>POGZ</i> expanding the spectrum of White-Sutton syndrome: A case reportAlain Chebly, Nabiha Salem, Romy Moussallem, et al.
Frontiers in Oncology|June 21, 2024
Spotlight on borderline-IGHV mutational status in chronic lymphocytic leukemiaSouraya Rammal, Warde Semaan, Natalia Aprahamian, et al.
Biogerontology|September 2, 2024
The impact of mosaic loss of the Y chromosome (mLOY) in men of advanced ageFarid Abou Abdallah, Christine Abdel Massih, Charbel Attieh, et al.
Biogerontology|November 2, 2023
T-cell lymphocytes' aging clock: telomeres, telomerase and agingAlain Chebly, Charbel Khalil, Alexandra Kuzyk, et al.
Pharmacogenomics|August 18, 2020
Whole-exome and whole-genome sequencing in chronic lymphocytic leukemia: new biomarkers to targetCharbel Hobeika, Gaelle Rached, Alain Chebly, et al.
Leukemia Research Reports|May 27, 2021
An unusual case of chronic lymphocytic leukemia with trisomy 12 and t(14;18) and a favorable response to ibrutinibFady Gh Haddad, Alain Chebly, Antoine El Sett, et al.
Pageof 4

Showing results (1-10 of 37) with videos related to

Sort By:
Pageof 4
Future Oncology (London, England)|August 12, 2024
Cancer cytogenetics in the era of artificial intelligence: shaping the future of chromosome analysisAlain Chebly
European Journal of Medical Genetics|June 3, 2026
Genotype before phenotype? Reversing the diagnostic odyssey in genomic medicineAlain Chebly, Said El Shamieh
Molecular Cytogenetics|July 18, 2025
Assessing the reliability of ChatGPT in cytogenetic reporting and interpretation: implications for clinical useAlain Chebly, Lauren Veronese, Edith Chevret
Ophthalmology Science|February 24, 2026
Long-read Sequencing in Inherited Retinal Dystrophies: A Systematic ReviewMariam Ibrahim, Alain Chebly, Said El Shamieh
Heliyon|November 18, 2024
A novel nonsense variant in <i>POGZ</i> expanding the spectrum of White-Sutton syndrome: A case reportAlain Chebly, Nabiha Salem, Romy Moussallem, et al.
Frontiers in Oncology|June 21, 2024
Spotlight on borderline-IGHV mutational status in chronic lymphocytic leukemiaSouraya Rammal, Warde Semaan, Natalia Aprahamian, et al.
Biogerontology|September 2, 2024
The impact of mosaic loss of the Y chromosome (mLOY) in men of advanced ageFarid Abou Abdallah, Christine Abdel Massih, Charbel Attieh, et al.
Biogerontology|November 2, 2023
T-cell lymphocytes' aging clock: telomeres, telomerase and agingAlain Chebly, Charbel Khalil, Alexandra Kuzyk, et al.
Pharmacogenomics|August 18, 2020
Whole-exome and whole-genome sequencing in chronic lymphocytic leukemia: new biomarkers to targetCharbel Hobeika, Gaelle Rached, Alain Chebly, et al.
Leukemia Research Reports|May 27, 2021
An unusual case of chronic lymphocytic leukemia with trisomy 12 and t(14;18) and a favorable response to ibrutinibFady Gh Haddad, Alain Chebly, Antoine El Sett, et al.
Pageof 4